Write your message
Volume 18, Issue 9 (12-2015)                   J Arak Uni Med Sci 2015, 18(9): 74-84 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vaghef Mehrabani E, Vaghef Mehrabani L, Norouzi S, Ziyadi S, Homayouni Rad A. The Effect of Probiotics on Prevention and Treatment of Metabolic Syndrome-Associated Disorders. J Arak Uni Med Sci. 2015; 18 (9) :74-84
URL: http://jams.arakmu.ac.ir/article-1-3417-en.html
1- Tabriz University of Medical Sciences, Tabriz, Iran.
2- Tehran University of Medical Sciences, Tehran, Iran.
3- Department of Food Science and Technology, Tabriz University of Medical Sciences, Tabriz, Iran. , homayounia@tbzmed.ac.ir
Abstract:   (5139 Views)

Background: Metabolic syndrome, a concurrence of overweight and abdominal fat distribution, disturbed glucose and insulin metabolism, mild dyslipidemia and hypertension is among the most important issues that man deals with, in today's world. Probiotics are live microorganisms which, when administered in adequate amounts, can confer a health benefit on the host. The aim of the present study was to review the clinical evidence available regarding the role of probiotics in improvement of disorders associated with metabolic syndrome.

Materials and Methods: In this research, clinical trials performed between 2000-2014 were searched in two databases, Pubmed and ScienceDirect. In both databases “Probiotics”, “metabolic syndrome” and each of its elements were used as the key words.

Results: Probiotics may reduce body weight through manipulating the gut flora. Through reducing inflammation and immune-regulation, probiotics decrease insulin resistance. They also improve lipid profile through reducing cholesterol absorption and producing short chain fatty acids, as well as deconjugating bile acids and converting cholesterol to coprostanol. Moreover, probiotics have been suggested to have a hypotensive effect through release of angiotensin-converting enzyme inhibitory peptides, through proteolytic action. 

Conclusion: Although some clinical trials have failed to obtain beneficial effects of probiotics on metabolic syndrome related situations, a majority of the studies have shown positive results for these microorganisms in this regard. Thus, probiotics can be looked upon as a novel approach when either prevention or alleviation of metabolic syndrome is aimed.

Full-Text [PDF 573 kb]   (1947 Downloads)    
Type of Study: Review Article | Subject: Nutrition
Received: 2015/01/10 | Accepted: 2015/08/16

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb